Literature DB >> 28585279

Serum bile acid level and fatty acid composition in Chinese children with non-alcoholic fatty liver disease.

Li Ping Lu1,2,3,4,5, Yan Ping Wan5, Peng Cheng Xun6, Ke Jun Zhou3,4, Cheng Chen6, Si Yang Cheng2,3,4, Min Zhong Zhang2,3,4, Chun Hua Wu7, Wei Wei Lin8, Ying Jiang5, Hai Xia Feng5, Jia Lu Wang5, Ka He6, Wei Cai1,2,3,4.   

Abstract

OBJECTIVE: To determine serum bile acid (BA) and fatty acid (FA) profiles in Chinese children with non-alcoholic fatty liver disease (NAFLD).
METHODS: A total 76 children aged 4-17 years were categorized into three groups according to the presence and absence of as well as the severity of NAFLD, that is, non-NAFLD (control), mild and moderate to severe NAFLD groups, respectively, based on their liver ultrasonography findings. Serum BA and FA profiles were quantified separately by mass spectrometry and gas chromatography. General linear models were performed to assess the differences among the groups.
RESULTS: After adjusted for potential confounders, children with NAFLD had higher levels of chenodeoxycholic acid (CDCA), unconjugated primary BAs (CDCA + cholic acid) but lower levels of deoxycholic acid (DCA), taurodeoxycholic acid (TDCA), glycodeoxycholic acid (GDCA), total DCA (DCA + TDCA + GDCA), glycolithocholic acid (GLCA) and total lithocholic acid (GLCA + taurolithocholic acid) than children without NAFLD. As for FAs, children with mild and moderate to severe NAFLD had higher levels of n-7 monounsaturated FA.
CONCLUSIONS: Circulating BA and FA profiles may change in children with NAFLD. Further studies are needed to determine their associations and to understand the underlying mechanism of action.
© 2017 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  bile acids; children; fatty acids; non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2017        PMID: 28585279     DOI: 10.1111/1751-2980.12494

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  7 in total

1.  Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort.

Authors:  Wei Perng; Ellen C Francis; Harry A Smith; John Carey; Dongqing Wang; Katerina M Kechris; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 2.  Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease.

Authors:  Gemma Aragonès; Sergio González-García; Carmen Aguilar; Cristóbal Richart; Teresa Auguet
Journal:  Biomed Res Int       Date:  2019-01-02       Impact factor: 3.411

3.  Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity.

Authors:  Yunjing Zhang; Xiaojiao Zheng; Fengjie Huang; Aihua Zhao; Kun Ge; Qing Zhao; Wei Jia
Journal:  Front Pharmacol       Date:  2019-07-25       Impact factor: 5.810

4.  Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy.

Authors:  Chance S Friesen; Chelsea Hosey-Cojocari; Sherwin S Chan; Iván L Csanaky; Jonathan B Wagner; Brooke R Sweeney; Alec Friesen; Jason D Fraser; Valentina Shakhnovich
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-13       Impact factor: 5.555

Review 5.  Roles of Palmitoleic Acid and Its Positional Isomers, Hypogeic and Sapienic Acids, in Inflammation, Metabolic Diseases and Cancer.

Authors:  Miguel A Bermúdez; Laura Pereira; Cristina Fraile; Laura Valerio; María A Balboa; Jesús Balsinde
Journal:  Cells       Date:  2022-07-08       Impact factor: 7.666

6.  Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.

Authors:  Dana Friedrich; Hanns-Ulrich Marschall; Frank Lammert
Journal:  BMC Gastroenterol       Date:  2018-06-04       Impact factor: 3.067

7.  Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.

Authors:  Hongshan Li; Yingfei Xi; Xin Xin; Huajie Tian; Yiyang Hu
Journal:  Nutr Metab (Lond)       Date:  2020-05-01       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.